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ARTIGO ORIGINAL 
PANORAMA OF CHIKUNGUNYA'S INCIDENCE BETWEEN 2014 
AND 2017: A COMPARATIVE BETWEEN TOCANTINS AND BRAZIL 
PANORAMA DA INCIDÊNCIA DE CHIKUNGUNYA ENTRE 2014 E 
2017: UM COMPARATIVO ENTRE TOCANTINS E BRASIL 
Gabriel Leal Costa Moura1, Beatriz Silva de Melo1, Lais Rodrigues Valadares1, 
Wanderson Batista Silva1, Fernando de Almeida Machado2. 
ABSTRACT 
Introduction: Chikungunya is an RNA virus of the genus Alphavirus, transmitted by Aedes 
ssp. Since 2005, few serious clinical cases and deaths had been associated with virus 
infection. Severe conditions became known after viral circulation in extensive epidemics. In 
Brazil, autochthonous transmission was detected only from 2014, whereas in Tocantins only 
from 2015. This study aims to evaluate and compare the incidence rates (IR) of 
Chikungunya from 2014 to 2017 of Tocantins and Brazil. Material and methods: this is a 
transversal, retrospective and descriptive evaluation, based on data provided by the 
Ministry of Health via the National System of Notifiable Diseases. IR were analyzed from 
2014 to 2017 of Tocantins and Brazil. Results: Chikungunya's IR in Tocantins went from 0 in 
2014 to 209.9 in 2017, with an increasing trend in the last three years. In Brazil, IR went 
from 0.03 in 2014 to 127 in 2016 and fell to 85.8 in 2017. Comparing IR from Tocantins and 
Brazil in 2017, the state's IR exceeded national by 244,63%. Discussion: The inclusion of 
Chikungunya among the differential diagnoses of arboviruses makes the national 
surveillance system to be subjected to difficulties inherent in epidemics. Underreporting 
and divergence in diagnostic criteria equally subject the number of possible cases. 
However, the fact that the growing IR in Tocantins does not follow the national reduction 
trend in the year 2017 may indicate other influential factors. Environmental conditions, 
coinfection, availability of agile diagnostic tests in health services and efficacy of preventive 
measures could justify such dissonance. Conclusion: The current situation of Chikungunya 
requires a more accurate follow-up, and the identification of the divergence in IR between 
Tocantins and Brazil can serve as a subsidy for new studies. 
Keywords: Arbovirus Infections; Chikungunya virus; Epidemiology; Health Incidence; 
Information Systems. 
 
RESUMO 
Introdução: O Chikungunya vírus é um RNA vírus do gênero Alphavirus, transmitido por 
vetores Aedes ssp. A partir de 2005, poucos casos clínicos graves e óbitos haviam sido 
associados a infecção pelo vírus. Quadros graves tornaram-se conhecidos após circulação 
viral em extensas epidemias. No Brasil, detectou-se transmissão autóctone apenas em 2014 
e no Tocantins a partir de 2015. Este trabalho objetiva avaliar e comparar as taxas de 
incidência (TI) da Chikungunya de 2014 a 2017 do Tocantins e do Brasil. Material e 
métodos: trata-se de uma avaliação transversal, retrospectiva e descritiva, baseada nos 
dados fornecidos pelo Ministério da Saúde via Sistema Nacional de Agravos Notificáveis. 
Foram analisadas as TI de 2014 a 2017 do Tocantins e do Brasil. Resultados: A TI da 
Chikungunya no Tocantins partiu de 0 em 2014 para 209,9 em 2017, com tendência nos 
últimos três anos sempre crescente. Já no Brasil, a TI saiu de 0,03 em 2014, atingindo a 
máxima de 127 em 2016 e queda para 85,8 em 2017. Comparando as TI do Tocantins e 
Brasil, em 2017, a do estado superou a nacional em 244,63%. Discussão: A inclusão da 
Chikungunya entre os diagnósticos diferenciais de arboviroses faz com que o sistema de 
vigilância nacional seja então submetido a dificuldades inerentes às epidemias. A 
subnotificação e a divergência nos critérios diagnósticos sujeitam por igual os números de 
casos possíveis. Todavia, o fato da TI crescente no Tocantins não acompanhar a tendência 
nacional de redução no ano de 2017 pode indicar outros fatores influentes. Condições 
ambientais, coinfecção, disponibilidade de exames diagnósticos ágeis nos serviços de saúde 
e eficácia das medidas preventivas poderiam justificar tal dissonância. Conclusão: A 
situação atual da Chikungunya requer um seguimento mais apurado, e a identificação da 
divergência na TI entre Tocantins e Brasil pode servir de subsídio para novos estudos.    
Palavras-chave: Epidemiologia; Incidência; Infecções por Arbovírus; Sistemas de 
Informação em Saúde; Vírus Chikungunya. 
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INTRODUCTION 
Chikungunya (CHIKV) is an RNA virus of the 
Togaviridae family of the genus Alphavirus, first described in 
1950 in the region that today corresponds to Tanzania, during 
an outbreak originally attributed to the Dengue virus1. The 
name Chikungunya means "one who bows" in the Makonde 
language, spoken in various parts of East Africa, the reason for 
the antalgic position that patients acquired during the disease 
period2. 
After the first reports, two distinct transmission 
patterns were described: one wild and periurban in Africa 
(Aedes ssp) and another urban in Asia (A. aegypti)1. Besides, 
three different genotypes were reported circulating in regions 
of the planet: the ECSA genotype, initially found in Central / 
South / East Africa; the WA, in West Africa; and Asia3. Until 
then, few serious clinical cases and no deaths had been 
associated with CHIKV infections1. 
Since 2005, small mutations in the E1 protein of the 
viral envelope in the ECSA variant allowed better adaptation 
of the agent to another cosmopolitan vector (Aedes 
albopictus)4. This fact contributed to a great dissemination of 
the disease to the Indian Ocean and later to Asia and Europe. 
Also in 2005, CHIKV arrived in the Reunion Islands after an 
outbreak in Kenya5. In this epidemic, which reached about 
40% of the population, many serious cases were documented 
and laboratory confirmed with lethality estimated in 1/1,000 
cases6. 
Chikungunya is characterized by fever associated with 
intense and debilitating joint pain, headache, myalgia, and by 
polyarthritis and symmetric polyarthralgia (mainly of them in 
wrists, ankles and elbows). This clinical condition, in general, 
improves after 10 days, however, the joint involvement can 
last for months, thus distinguishing itself from Dengue7. The 
proportion of chronic cases varied in different epidemics in 
France, South Africa and the islands of the Indian Ocean, from 
4 to 63%6. 
Although severe conditions are uncommon and there 
are no major hemorrhagic shocks such as Dengue, there are 
some life threatening situations specially for infants and 
elderly, such as neurological manifestations (encephalitis, 
meningoencephalitis, myelitis, Guillain-Barré syndrome), 
cutaneous bullous and myocarditis5. 
Chikungunya presents characteristics that amplify the 
spread of the disease and increase the possibility of large and 
explosive epidemics8. Among these characteristics are the 
large proportion of symptomatic cases (> 90%), short 
incubation period in humans (from two to seven days) and 
viremia period of two days before and ten days after fever7. 
Viral replication in Aedes albopictus mosquito, in addition to 
A. aegypti, increases geographical extension of regions with 
viral circulation potential8. 
In Brazil, autochthonous transmission of Chikungunya 
fever occurred initially in 2014, when 3,657 suspected cases 
were reported in eight cities in different states of the North, 
Northeast and Central West regions9,10. Once the sustained 
transmission of CHIKV in a certain area has been established 
with laboratory confirmation of the first cases, Ministry of 
Health of Brazil recommends that further cases should be 
confirmed by clinical-epidemiological criteria10. 
The diseases of the dengue-like syndrome are a great 
challenge due to the non-specificity of the prodromal period 
and the difficulty of obtaining the serological diagnosis, facts 
that demand a greater technical capacity of the professional 
to recognize early clinical criteria that approach the definitive 
diagnosis. In this sense, the occurrence of simultaneous 
epidemics makes difficult the correct diagnosis and clinical 
management due to the peculiarities of Dengue fever and 
Chikungunya fever11. 
Concerning Tocantins, which is a young and large 
geographic state, insertion of a new agent constitutes a new 
obstacle to the local health system, considering that the state 
has few qualified medical centers to face crisis situation and 
epidemic emergency. It is responsibility of the scientific 
community, associated with health services, to monitor the 
epidemiological situation, transmission patterns in Brazil, 
impact of the disease and mainly to contribute with the 
proposal of measures to face this large emerging challenge. 
As a result, the objective of this study was to analyze 
the incidence coefficients of CHIKV infection in Tocantins and 
in Brazil, taking the temporal cut between 2014 and 2017, and 
comparing them year by year, associating related factors. 
 
MATERIALS AND METHODS 
 
This study was developed in a cross-sectional, 
retrospective and descriptive manner, based on data from the 
Brazilian Ministry of Health, included in the National System of 
Notifiable Injuries and was published through epidemiological 
bulletins. The incidence data of Chikungunya fever from 2014 
to 2017 of Tocantins and Brazil were analyzed, considering up 
to the 36th epidemiological week (EW) in 2014 and 2015, and 
up to the 37th EW in 2016 and 2017, with a view to the 
uniformity and opportuneness of comparisons. 
For this study, only the probable cases of 
Chikungunya were considered, which are all reported cases, 
excluding those discarded by negative laboratory diagnosis, 
with timely collection, or diagnosed for other diseases. 
The analysis was done by calculating the incidence 
coefficient, based on the absolute number of cases and the 
official population (which was made available by the Brazilian 
Institute of Geography and Statistics) for the federation unit in 
question, Tocantins, and for the nation. Tocantins is the 
newest state of the Brazilian republic, having been created by 
the Federal Constitution of 1988, for that reason, its reality is 
very particular in relation to the other states of the country. 
Once the analyzes were made, the findings were 
discussed, confronting them with the literature and making 
inferences that allowed to fill in the gaps that were found, 
thus pointing to the considerations that were made at the end 
of this study. 
Since it did not involve human beings directly, this 
study was not forced to pass through the evaluation of a 
Research Ethics Committee. However, the ethical dictates 
have been respected, which apply to the situation, within the 
limits of the Helsinki Declaration. 
 
RESULTS 
In 2014, 54 probable cases of Chikungunya were 
registered in 15 Brazilian states, rising to 23,431 probable 
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cases in 2015, distributed in all 26 states of the country. In 
2016, there were 264,110 probable cases; and 176,901 in 
2017 (Table 1). In Tocantins, in 2014 there were no registered 
cases. In 2015 there were 15 probable cases, rising to 1,230 
probable cases in 2016 and 3,218 in 2017 (Table 2). 
Table 1: Probable cases and Incidence Rate of Chikungunya in 
Brazil, from 2014 to 2017. 
Year Probable cases in Brazil Incidence Rate in Brazil 
(/100.000 hab) 
2014 54  0,03 
2015 23.431  11,5 
2016 264.110  128,2 
2017 176.901  85,8 
 
Table 2: Probable cases and Incidence Rate of Chikungunya in 
Tocantins, from 2014 to 2017 
Year Probable cases Incidence Rate in Tocantins 
(/100.000 hab) 
2014 0 0 
2015 15 1 
2016 1230 80,2 
2017 3218 209,9 
 
Regarding the incidence rates, the Tocantins went 
from 0 in 2014 to 209.9/100,000 inhabitants in 2017, with 
increasing trend in the three years. In Brazil, the incidence rate 
went from 0.03/100,000 inhabitants in 2014, reaching a 
maximum of 128.2/100,000 inhabitants in 2016 and falling to 
85.8/100,000 inhabitants in 2017 (Figure 1). Comparing the 
incidence rates of Tocantins in relation to Brazil, in the last 
record of 2017, the state surpassed the national by 244.63%. 
 
Figure 1: Comparison between incidence rates of Tocantins 
and Brazil from 2014 to 2017. 
 
DISCUSSION 
 
The inclusion of Chikungunya among the differential 
clinical diagnoses of the dengue-like syndrome implies an 
intense dissemination of the disease among health teams 
throughout Brazil11. In addition, co-circulation of Dengue, 
Chikungunya and Zika infection in Brazil makes clinical 
management difficult due to similarities, has implications 
concerning transmission in elderly, pregnant women and 
children, and has a limited laboratory back-up, although its 
impact is not well known9. 
The introduction of any arbovirus in an indene area 
or in areas with the presence of the vector should never be 
neglected9, a fact that was confirmed by the rapid expansion 
of the cases throughout the national territory since the 
insertion of CHIKV in the country in 2014. 
In doing so, the expansion of the areas of CHIKV 
infection and other arboviruses in Brazil is associated with 
urbanization, without the proper sanitation infrastructure, 
which is a mark of the developing economies, and with the 
economic globalization12. These factors contribute not only to 
the active dispersal of the mosquito, but also to dissemination 
of the serotypes previously circumscribed to certain 
geographic areas, a fact corroborated by the intense migratory 
flow13. This reflection of the contemporary and globalized 
world has increasingly brought CHIKV to areas previously 
indenes or even importing serotypes previously present only 
in other regions13. 
Literature also mentions that the incidence fluctuates 
within the months of the year according to climatic factors, so-
called seasonal increase of rates. It is associated to the 
temperature increase, rainfall and humidity of the air: 
conditions that favor the increase in the number of available 
breeding places, the survival of the vector and its density, 
which is, as far as we know, the greatest determinant for the 
growth of the coefficients of incidence around the world, 
especially in the humid tropics14,15. 
The spread of the disease throughout Latin America 
was enough to establish an emergency situation by the World 
Health Organization (WHO) two years after the onset of the 
outbreak on the global stage. At this juncture, Brazil stands 
out as the country with the highest number of cases 
registered up to 2016 comparing it to Latin American 
countries9,16. 
However, countries such as Bolivia, Honduras, and 
Aruba surpassed Brazil in terms of incidence of the disease, 
besides Colombia having excelled in presenting the highest 
rate of lethality16. Interestingly, until then the Ministry of 
Health of Colombia did not accept CHIKV and ZIKV as causes of 
death, although published studies by Colombian researchers 
confirmed deaths due to ZIKV17,18. 
Still on the global stage, Caribbean countries, where 
the outbreak of CHIKV infection in the Americas started in the 
beginning of the year 2017, were characterized by high 
incidence rates for the disease, especially Aruba, which in 
epidemiological week 1 presented a rate of incidence of 
821.93/100,000 inhabitants16. 
The perplexity regarding the dissemination of the 
ZIKV and the CHIKV and its impact in Brazil culminated in the 
establishment of an emergency situation in public health by 
the Brazilian Ministry of Health9. The significant decline in the 
number of probable cases verified in 2017 in Brazil could be 
attributed to the consequent resources movement and 
articulations between states and cities. The execution of the 
arbovirus control policy is carried out with treasury resources 
of each state and through intergovernmental transfers of 
resources19. 
Mosquitos of the genus Aedes spp are the main 
vectors of Dengue, Zika and Chikungunya, which means that 
the strategies of prevention of these diseases and vector 
control will impact on the three arboviruses, optimizing 
0,03
11,5
128,2
85,8
0 1
80,2
209,9
2014 2015 2016 2017
Incidence rate in Brazil (/100.000 hab)
Incidence rate in Tocantins (/100.000 hab)
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resources and efforts20,21. Therefore, it would be possible to 
suppose that the diligences adopted as a response of the 
Brazilian government to the increased prevalence of 
microcephaly caused by ZIKV had repercussions on the 
national reduction in the incidence of Chikungunya observed 
by the study. However, for some authors, the actions 
developed in the cities have not been shown to be effective in 
reducing Aedes infestation in most of the country20. 
It is known that there may be some restrictions 
related to the quality of the information available to carry out 
risk mapping for arboviruses20. Although the dengue 
surveillance system in Brazil was shown to be consistent and 
opportune for case reporting, difficulties for the differential 
diagnosis of dengue-like syndromes were imposed after the 
introduction of the new viruses, which may interfere the 
quality of the information provided by the Ministry of 
Health20. In the absence of the serological diagnosis, which is 
the definitive one, the professional's diagnostic impression, 
based on well-defined clinical criteria and correctly validated 
by the medical literature, is essential for correct notification of 
the complaint, thus producing reliable indicators, subsidizing 
observation to the point of guiding public policies22. 
Underreporting and divergence in available clinical 
and laboratorial diagnostic criteria on a large scale subject the 
numbers of probable cases to equivocation. The fact that the 
growing incidence rate in Tocantins does not follow the 
national reduction trend in the year 2017 may indicate other 
influential factors. 
Environmental conditions influence as the tropical 
climate with two well-defined seasons - a drought and a rainy 
season -, associated with the population growth of Brazil's 
newest state, favor the formation of artificial oviposition sites, 
such as disposal materials that can serve as reservoir for 
standing water23. However, this factor alone is not enough to 
explain the dissonance of the results between Tocantins and 
Brazil. 
Concerning the change in the incidence in Tocantins 
due to the cocirculation of arboviruses that compete for the 
same vector in the state, such as Chikungunya, Zika and 
Dengue, there are no studies that show the relation of this 
cocirculation with the increased incidence of the disease. The 
risk, in this case, is associated with a co-infection that can be 
serious, as described in cases in the state of Pernambuco24. 
Ineffectiveness of preventive measures in the state is 
a condition to be considered. There is a need for weekly 
efforts to clean the water reservoirs, also associated with 
measures of individual protection against stings in the early 
morning and late afternoon (habit not very verified in the 
population behavior), since the vector makes the eggs 
deposition in any proximity to the reservoir, having an 
extremely fast life cycle25. 
In this perspective, the recent observation of the 
epidemiological phenomenon and the lack of analyzes aimed 
at elucidating the dissonance between the incidence rates 
considered in the present study preclude the realization of 
more precise inferences9. 
Finally, efforts to develop agile and sensitive 
diagnostic tests, specific immunobiological and antiviral drugs 
are essential9. Laboratory tests that allow early diagnosis, 
even in the prodromal period, are of great value with a view 
to secondary prevention. As a result, it would minimize the 
risks of complications and contribute to a reduction of the 
morbid process, sparing both human and monetary resources 
for Brazil's already desolated health care system. On the other 
hand, the launch of drugs that are effective in eradicating the 
infection once it is installed is a great search niche, since such 
active principles would play a decisive role in the natural 
history of the disease, treating infection and preventing 
complications, not only adopting palliative efforts during the 
period of CHIKV infection. 
 
CONCLUSION 
 
Chikungunya’s importance runs through many 
aspects, from the epidemic issue to the evidence of severe 
illness. Besides the arthralgia followed by fever, nausea and 
vomiting, many patients also develop subacute forms of the 
disease, with prolonged symptomatology for several weeks, 
and others, the chronic form, with arthritis and severe 
arthritis, which arise and cause pain and limitations in the 
patients for many years11. 
Regarding management, coping with emerging 
arboviruses requires broad-spectrum policies and 
interventions, involving various society's sectors, not only 
health9. This way, epidemiological research should be part of 
national public health surveillance routines and concerns to 
predict new emergencies9. Joint actions in research and the 
fight against vectors can impact on the spread of emerging 
viruses9. 
The combination of more efficient vector control, 
which impacts the transmission force of the disease, and the 
vaccination of large population groups, which reduces the 
proportion of susceptible individuals, seems to be a promising 
strategy. However, realistically, the lack of an effective and 
cost-effective vaccine against CHIKV and the unavailability of 
specific treatment and immunobiological still affirm the role of 
the fight against Aedes aegypti as a central strategy for the 
containment of arboviruses. Nevertheless, vector control will 
only succeed if it can incorporate new technologies and tools 
that can, jointly with those already in force, achieve more 
satisfactory results, which are proven to reduce disease 
burden and not only improve entomological indicators. 
Chikungunya’s current situation requires more 
accurate follow-up. The Tocantins conditions that allowed the 
virus to spread must be intervened in order to interrupt its 
rapid spread and the consequent disease morbidity. Thus, the 
identification of divergence in the incidence rates of 2017 
between Tocantins and Brazil may serve as a subsidy for new 
studies that follow, perhaps for a longer time, the panorama 
of the disease. 
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